|
|
Volumn 310, Issue 3, 2013, Pages 246-247
|
|
Panel recommends easing restrictions on rosiglitazone despite concerns about cardiovascular safety
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
METFORMIN;
PIOGLITAZONE;
PLACEBO;
ROSIGLITAZONE;
SULFONYLUREA;
CARDIOVASCULAR EFFECT;
CARDIOVASCULAR MORTALITY;
CARDIOVASCULAR RISK;
CONSULTATION;
DEATH;
DRUG APPROVAL;
DRUG INFORMATION;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TREATMENT FAILURE;
DRUG USE;
FOOD AND DRUG ADMINISTRATION;
FRACTURE;
GLYCEMIC CONTROL;
HEALTH CARE ACCESS;
HEART FAILURE;
HEART INFARCTION;
HIGH RISK PATIENT;
HUMAN;
MEDICAL DECISION MAKING;
MORBIDITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OBSERVATIONAL STUDY;
POSTMARKETING SURVEILLANCE;
PRESCRIPTION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
SHORT SURVEY;
|
|
EID: 84880274050
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2013.8141 Document Type: Short Survey |
|
Times cited : (22)
|
|
References (0)
|
